Authors: VANHOUTEN AA HAAGEN IA CLARK M GEERARS A DELAU W BAST EJEG DEGAST GC

Citation: Aa. Vanhouten et al., FIRST RESULTS OF INTRAVENOUS APPLICATION OF BISPECIFIC ANTIBODY (CD3 CD19 SHR-1) TO PATIENTS WITH CD19 POSITIVE B-CELL MALIGNANCIES - A PHASE-1 STUDY/, Experimental hematology, 21(8), 1993, pp. 1120-1120

Authors: VANHOUTEN AA HAAGEN IA CLARK M GEERARS A DELAU W VROOM TM BAST EJEG DEGAST GC

Citation: Aa. Vanhouten et al., CYTOKINE RELEASE AFTER INTRAVENOUS ADMINISTRATION OF BISPECIFIC ANTIBODY (CD3 CD19, SHR-1) - A PHASE-I STUDY IN PATIENTS WITH CD19 POSITIVEB-CELL MALIGNANCIES/, Blood, 82(10), 1993, pp. 10000580-10000580